TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.
Equities
T14
CNE100000924
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.44 USD | +2.52% |
|
-3.56% | +17.87% |
| 15/05 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Directorate and Committee Changes | CI |
| 30/04 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
Evolution of the average Target Price on Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Price target over the last 5 years
History of analyst recommendation changes
05.Qeo_LB7_AFufw4kO5QL-0i57YLpxQa3WanFI-LbAbXE.cKJHZlqNS2LysvFRkDCfn3wKV8M6APzmA0EAndn0ADssk0hJedJVF-aLxA~712ac65e92a925f069d7ba49928a58d2
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
32.9
CNY
Average target price
45.8
CNY
Spread / Average Target
+39.21%
High Price Target
45.8
CNY
Spread / Highest target
+39.21%
Low Price Target
45.8
CNY
Spread / Lowest Target
+39.21%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
- T14 Stock
- Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
